TrialPath

Find a study

Match me to a study

17 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

ListMap
Weight & metabolicMental healthLungs & breathingHeart & circulationKidneyBrain & memoryBlood disordersImmune & autoimmuneSkin

13 studies on the map

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease — Stanford University Medical Center, StanfordMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — University of Alabama Saint Vincent's Birmingham, BirminghamPiMZ Longitudinal Cohort (PiMZ Logic) — University of Alabama at Birmingham, BirminghamSAD Study in Patients With Parkinson's Disease and Motor Fluctuations — Rocky Mountain Clinical Research, EnglewoodProspective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod — University of Colorado Anschutz Medical Campus, AuroraPrevention of Progression of Prediabetes, Obesity and CV Risk — University of Texas Health Science Center at San Antonio, San AntonioNew Heart Imaging Techniques to Evaluate Possible Heart Disease — National Institutes of Health Clinical Center, BethesdaFeasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD — University of Michigan, Ann ArborFeasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD — University of Tennessee Medical Center, KnoxvilleNeurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD — John D. Dingell VA Medical Center, Detroit, MI, DetroitInter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction — Beth Israel Deaconess Medical Center, BostonBlood Pressure Effects on Cognition and Brain Blood Flow in PD — University of California San Diego, San DiegoThis Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis. — Washington University in St. Louis, St Louis